| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group
|
Bookman, M.A.
|
|
|
11 |
S1 |
p. 42-51
|
artikel
|
| 2 |
Early stage ovarian cancer: the Italian contribution to clinical research. An update
|
Favalli, G.
|
|
|
11 |
S1 |
p. 12-19
|
artikel
|
| 3 |
Gemcitabine in the treatment of ovarian cancer
|
Hansen, S.W.
|
|
|
11 |
S1 |
p. 39-41
|
artikel
|
| 4 |
High dose chemotherapy in ovarian cancer
|
Pujade-Lauraine, E.
|
|
|
11 |
S1 |
p. 64-67
|
artikel
|
| 5 |
Impact of new non-cytotoxics in the treatment of ovarian cancer
|
Eisenhauer, E.
|
|
|
11 |
S1 |
p. 68-72
|
artikel
|
| 6 |
Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)
|
Vermorken, J.B.
|
|
|
11 |
S1 |
p. 73-76
|
artikel
|
| 7 |
Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer
|
Hager, E.D.
|
|
|
11 |
S1 |
p. 57-63
|
artikel
|
| 8 |
Introduction
|
Vermorken, Jan B.
|
|
|
11 |
S1 |
p. 1-2
|
artikel
|
| 9 |
Ovarian cancer screening in the general population: current status
|
Menon, U.
|
|
|
11 |
S1 |
p. 3-6
|
artikel
|
| 10 |
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
|
Tropé, C.
|
|
|
11 |
S1 |
p. 20
|
artikel
|
| 11 |
Remarks and conclusions on ovarian cancer treatment
|
Poveda, A.
|
|
|
11 |
S1 |
p. 77-81
|
artikel
|
| 12 |
Second-line treatment and consolidation therapies in advanced ovarian cancer
|
Conte, P.F.
|
|
|
11 |
S1 |
p. 52-56
|
artikel
|
| 13 |
The integration of anthracyclines in the treatment of advanced ovarian cancer
|
Lück, H.-J.
|
|
|
11 |
S1 |
p. 34-38
|
artikel
|
| 14 |
The integration of docetaxel into first-line chemotherapy for ovarian cancer
|
Kaye, S.B.
|
|
|
11 |
S1 |
p. 31-33
|
artikel
|
| 15 |
The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer
|
Vermorken, J.B.
|
|
|
11 |
S1 |
p. 21-30
|
artikel
|
| 16 |
The role of molecular biology in understanding ovarian cancer initiation and progression
|
Bingham, C.
|
|
|
11 |
S1 |
p. 7-11
|
artikel
|
Tijdschrift beschrijving